Results 221 to 230 of about 881,201 (350)

Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Ablation of ventricular tachycardia (VT) is often performed in patients with structural heart disease. Procedural and delayed enhancement cardiac magnetic resonance imaging (DE‐CMR) characteristics among patients with very severe cardiomyopathy (CM) and without left‐ventricular assist devices (LVAD) have been incompletely described.
Michael Ghannam, Nathanial Christian‐Miller, Jackson Liang, Amrish Deshmukh, Kelly Arps, Rakesh Latchamsetty, Thomas Crawford, Krit Jongnarangsin, Hakan Oral, Fred Morady, Frank Bogun   +10 more
wiley   +1 more source

Development and validation of a nomogram for predicting survival in patients with cardiogenic shock. [PDF]

Front Cardiovasc Med
Fang D, Chen H, Geng H, Chen X, Liu M.
europepmc   +1 more source

A Standardized and Regionalized Network of Care for Cardiogenic Shock.

JACC. Heart failure, 2022
Behnam N. Tehrani, M. Sherwood, Carolyn M. Rosner, A. Truesdell, Seiyon Ben Lee, Abdulla A. Damluji, M. Desai, Shashank S. Desai, K. Epps, M. Flanagan, E. Howard, Nasrien E Ibrahim, J. Kennedy, Hala Moukhachen, M. Psotka, Anika Raja, I. Saeed, P. Shah, Ramesh Singh, S. Sinha, Daniel G. Tang, Timothy S. Welch, K. Young, C. Defilippi, A. Speir, Christopher M. O’Connor, W. Batchelor   +26 more
semanticscholar   +1 more source

Fascicular/Purkinje Tissue Colocalized With Scar in Cardiomyopathy Patients Undergoing Ventricular Fibrillation Ablation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Ventricular fibrillation (VF) is a poorly understood arrhythmia that is one of the main mechanisms of sudden cardiac death in patients with structural heart disease (SHD). Fascicular and Purkinje tissue (FPT) has been implicated in VF.
Emir Baskovski, Timucin Altin, Omer Akyurek, Turkan Seda Tan, Mahmut EkremCunetoglu, Irem Muge Akbulut, Volkan Kozluca, Nail Burak Ozbeyaz, Eralp Tutar   +8 more
wiley   +1 more source

SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/CABG—trial design

, 1999
Judith S. Hochman, Lynn A. Sleeper, Emilie Godfrey, Sonja M. McKinlay, Timothy A. Sanborn, Jacques Col, Thierry H. LeJemtel   +6 more
openalex   +1 more source

Application of “double bridge mechanical” resuscitation for profound cardiogenic shock leading to cardiac transplantation [PDF]

, 2001
Frank W. Bowen, A Carboni, Mary Lou O’Hara, Alberto Pochettino, Bruce R. Rosengard, Rohinton J. Morris, Robert C. Gorman, Joseph H. Gorman, Michael A. Acker   +8 more
openalex   +1 more source

Understanding cardiogenic shock [PDF]

European Journal of Heart Failure, 2015
openaire   +4 more sources

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery

Transfusion, EarlyView.
Abstract Background Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Magali J. Fontaine, Jackline J. M. Lasola, Aidaelis Martinez‐Hernandez, Juliana N. Marshall, Soren Bentzen, Min Zhan, Parvez M. Lokhandwala, Kenichi Tanaka, Carlos H. Villa, Alexis Jones, Chintamani D. Atreya, Reney A. Henderson   +11 more
wiley   +1 more source

Postpartum pheochromocytoma crisis associated with cardiogenic shock and Sheehan's syndrome. [PDF]

BMJ Case Rep
Wall D, Nieding K, Scheuba C, Haug A, Schmook M, Kiefer FW.   +5 more
europepmc   +1 more source

Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

, 1997
R. David Anderson, E. Magnus Ohman, David R. Holmes, Jacques Col, Amanda Stebbins, Eric R. Bates, Robert J. Stomel, Christopher B. Granger, Eric J. Topol, Robert M. Califf   +9 more
openalex   +1 more source